Congleton Joninsider trades

In SEC Form 4 filings, Congleton Jon is listed as Chief Executive Officer of Mineralys Therapeutics, Inc. (MLYS). In the last 90 days, Congleton Jon sold $1.91M of Mineralys Therapeutics, Inc. (MLYS) on the open market and bought none. The sale was reported under a 10b5-1 trading plan.

Companies and roles

Company	Role	Transactions	Last filed
MLYSMineralys Therapeutics, Inc.	Chief Executive Officer	1	Oct 2

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-10-02

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
MLYSMineralys Therapeutics, Inc.	Sep 30	Oct 2	S	75,000	$25.46	Sale −$1,909,665	528,621	Yes	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.